The role of MSCs and CAR-MSCs in cellular immunotherapy.

Yan, Lun; Li, Jing; Zhang, Cheng

Yan, Lun; Li, Jing; Zhang, Cheng.

Afiliación

Yan L; Medical Center of Hematology, State Key Laboratory of Trauma, Burn and Combined Injury, Xinqiao Hospital, Army Medical University, Chongqing, 400037, China.
Li J; Medical Center of Hematology, State Key Laboratory of Trauma, Burn and Combined Injury, Xinqiao Hospital, Army Medical University, Chongqing, 400037, China.
Zhang C; Medical Center of Hematology, State Key Laboratory of Trauma, Burn and Combined Injury, Xinqiao Hospital, Army Medical University, Chongqing, 400037, China. chzhang2014@163.com.

Cell Commun Signal ; 21(1): 187, 2023 08 01.

Article en En | MEDLINE | ID: mdl-37528472

Asunto(s)

Células Madre Mesenquimatosas; Neoplasias; Receptores Quiméricos de Antígenos; Humanos; Linfocitos T; Inmunoterapia; Neoplasias/terapia; Microambiente Tumoral

Palabras clave

CAR; CAR-DCs; CAR-Ms; CAR-NK cells; CAR-T cells; Exosome; Immunomodulation; Immunotherapy; Mesenchymal stem cell

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Células Madre Mesenquimatosas / Receptores Quiméricos de Antígenos / Neoplasias Límite: Humans Idioma: En Revista: Cell Commun Signal Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google